Skip To Main Content
Lilly
Menu closed
Lilly
  • Account Login / Register
  • Medical Home
  • Medical Education
      • All Therapeutic Areas
        • Alopecia Areata
        • Atopic Dermatitis
        • Dermatology
        • Psoriasis
        • Diabetes
        • Hypoglycemia
        • Inflammatory Bowel Disease
        • Crohn's Disease
        • Ulcerative Colitis
        • Migraine
        • Alzheimer's Disease
        • Cognitive Health
        • Obesity
        • Obstructive Sleep Apnea
        • Breast Cancer - Early
        • Breast Cancer - Metastatic
        • Hematological Malignancy
        • Non-Small Cell Lung Cancer
        • Oncology Precision Medicine
        • Thyroid Cancer
        • Axial Spondyloarthritis
        • Psoriatic Arthritis
        • Resources
      • All Therapeutic Areas
        • Alopecia Areata
        • Atopic Dermatitis
        • Psoriasis
        • Diabetes
        • Hypoglycemia
        • Inflammatory Bowel Disease
        • Cluster Headache
        • Migraine
        • Alzheimer's Disease
        • Cognitive Health
        • Obesity
        • Obstructive Sleep Apnea
        • Breast Cancer - Metastatic
        • Gastrointestinal Cancer
        • Hematological Malignancy
        • Oncology
        • Osteoporosis
        • Rheumatoid Arthritis
        • Resources
  • Independent Medical Education
    • Cardiovascular
      • Alopecia Areata
      • Atopic Dermatitis
      • Psoriasis
      • Diabetes
      • Crohn's Disease
      • Ulcerative Colitis
      • Migraine
      • Alzheimer's Disease
      • Obesity
      • Obstructive Sleep Apnea
      • Breast Cancer
      • Gastrointestinal Cancer
      • Hematological Malignancy
      • Non-Small Cell Lung Cancer
      • Oncology
      • Oncology Precision Medicine
      • Prostate Cancer
      • Axial Spondyloarthritis
      • Psoriatic Arthritis
  • Chat Contact Us
Lilly

You are now leaving the Lilly Medical Education website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical Education.

Type 2 Diabetes Patient Case Simulation

Loading icon

Case Simulation 1

CLINIC-Sim: Simulating a Patient-Centered Approach to Optimize Early Glycemic and Weight Control in Type 2 Diabetes

Learn more about glycemic control and weight management in type 2 diabetes

Start Simulation
View Program Overview

Shared Decision-Making Resources

Watch an expert video on shared decision-making and download the conversation starter to aid in your patient interactions

Related Resources

These videos were commissioned by Lilly and are intended to be used by HCPs who treat diabetes for medical, scientific and educational purposes.

Video content is not approved for continuing education credit.

Disclosures:
Dr. Matt Capehorn

Unpaid:

  • Board member of the Association for the Study of Obesity (ASO)
  • Faculty member of the Primary care Academy of Diabetes Specialists (PCADS)
  • Expert Advisor to NICE
  • Professional Advisor to the Obesity Empowerment Network (OEN)

Paid:

  • Director – RIO Weight management Limited
  • Medical Director – Lighterlife (commercial VLCD company)
  • Ad-hoc Medical Advisor – McDonalds UK

Advisory Boards: Lilly, Boehringer Ingelheim, Novo Nordisk; Speaker fees/travel: Lilly, Boehringer Ingelheim, Novo Nordisk; Research income (RIO): Lilly, Boehringer Ingelheim, Novo Nordisk

Patient Information

An African American female with a body mass index of 33 kg/m2.

  • 47-year-old African American female
  • Diagnosed with T2D 9 months ago
  • HbA1c since diagnosis: 8.7%
  • Current treatment: 1000 mg metformin daily at diagnosis
  • Followed by registered dietitian/nurse educator

  • Prediabetes for 2 years preceding diagnosis, tried to manage with diet and exercise
  • Gestational diabetes with her second child
  • Hypertension
  • Obesity
  • Mixed dyslipidemia

  • T2D in father, maternal aunt
  • CAD in father
  • Hypertension in mother and father

  • Married, has 2 children ages 10 and 15
  • Never smoked or vaped, no illicit substances, rarely drinks alcohol
  • High school math teacher

  • Normal eGFR, normal urine microalbumin
  • BMI: 33 kg/m2 (195 lbs)
  • Blood pressure: 145/90 mmHg
  • Total cholesterol: 210 mg/dL
  • LDL cholesterol: 109 mg/dL
  • HDL cholesterol: 44 mg/dL
  • Triglycerides: 290 mg/dL

Follow-up notes
An African American female with a body mass index of 33 kg/m2.

9 months since diagnosis

The patient was diagnosed with type 2 diabetes, and her HbA1c was 8.7% at the time. She was started on 1000 mg metformin daily. During that visit, she was advised on lifestyle modifications, including dietary changes to help both her diabetes and hypertension management, as well as recommendations to incorporate exercise. She was encouraged to start a statin for dyslipidemia but was too overwhelmed by her diabetes and declined statin therapy.

At visit 2, her HbA1c decreased to 7.9%. She again declined a statin and agreed to start an ACE inhibitor. Her metformin was titrated to 1500 mg total daily dose.


13 months since diagnosis (4-month follow-up)

  • She returns 4 months later.
  • She is taking a dose of 1500 mg metformin daily (500 mg in the morning and 1000 mg in the evening) without missing doses. She was not able to tolerate a dose of 1000 mg twice daily. Her HbA1c has decreased to 7.7% from 7.9%, and her body weight remained stable.
    • BMI: 33 kg/m2 (195 lbs)
    • Blood pressure: 130/85 mmHg
    • Total cholesterol: 205 mg/dL
    • LDL cholesterol: 110 mg/dL
    • HDL cholesterol: 43 mg/dL
    • Triglycerides: 260 mg/dL
  • She increased her physical activity by parking farther and trying to walk more, but often struggles to find the time to get more exercise in.
  • She tries to eat more balanced meals with protein, vegetables and fewer carbohydrates; she finds it difficult to make multiple meals for her family members who prefer to keep to their old dietary routine.
  • She is motivated to continue working on lifestyle changes and has agreed to start a statin.

Go to question #1

  1. 1
  2. 2
  3. 3
Step 1 of 3

Question #1

In addition to continuing metformin 1500 mg daily, which of the following may be the next best step?

Option A:

Continue lifestyle modifications – she is very motivated and prefers not to start another medication

Option B:

Start a sulfonylurea and continue lifestyle modifications

Option C:

Start an incretin receptor agonist and continue lifestyle modifications

Option D:

Start a DPP-4 inhibitor

Related Resources

Play Video
Shared Decision-Making Video

Hear from Dr. Capehorn on collaborating with patients to individualize care.

VV-MED-145674

Patient-Physician Conversation Starter (PDF)

Tips and tricks to initiate patient centric conversations.

VV-MED-145677

Shared Decision-Making (PDF)

Support early glycemic control and weight management through shared decision-making.

VV-MED-148828

VV-MED-144376

Please rate your satisfaction with the content on the following statements:

Very Dissatisfied

Dissatisfied

Neutral

Satisfied

Very Satisfied

Credibility of information
Credibility of information
Relevance of the information to my needs
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice
Confidence to implement the learnings in my clinical practice

Please rate your satisfaction with the content on the following statements:

Credibility of information
Credibility of information
Very Satisfied
Very Dissatisfied
Relevance of the information to my needs
Relevance of the information to my needs
Very Satisfied
Very Dissatisfied
Confidence to implement the learnings in my clinical practice
Confidence to implement the learnings in my clinical practice
Very Satisfied
Very Dissatisfied
  • Copyright
  • Terms of Use
  • Privacy Statement
  • Consumer Health Privacy Notice
  • Accessibility Statement
  • Sitemap

To speak to customer support:
Call (XXX) XXX-XXXX

This site is intended for US Healthcare Professionals only.

4.4.53 05/2025 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2025. All rights reserved.

Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

California Consumer Privacy Act (CCPA) Opt-Out Icon Your Privacy Choices
Cookie Settings
Facebook X LinkedIn
Lilly